首页 | 本学科首页   官方微博 | 高级检索  
     

浅谈中药致肝损害的现状及其风险管理
引用本文:冯红云. 浅谈中药致肝损害的现状及其风险管理[J]. 中国药物警戒, 2010, 7(6): 356-358
作者姓名:冯红云
作者单位:国家食品药品监督管理局药品评价中心,北京,100045
摘    要:中药作为我国传统医学的重要组成部分,为人类健康做出了极大贡献。但随着中医药的大力发扬以及中西医结合疗法的发展,中药引起肝损害的事件也逐渐引起关注。通过分析中药致肝损害的现状及其发生因素,提出中药肝损害的预防及风险管理措施,为控制中药肝损害严重后果的发生提供建议。

关 键 词:中药  肝损害  风险管理

Hepatic Lesion Induced by Traditional Chinese Drug and Drug Risk Management
FENG Hong-yun. Hepatic Lesion Induced by Traditional Chinese Drug and Drug Risk Management[J]. Chinese JOurnal of Pharmacovigilance, 2010, 7(6): 356-358
Authors:FENG Hong-yun
Affiliation:FENG Hong-yun (Center for Drug Reevaluation,SFDA,Beijing 100045,China)
Abstract:Traditional Chinese Medicine,which is the important component of traditional Chinese medicine,has devoted to human being healthy. Along with the development of traditional medicine and integrated Chinese-western therapy,hepatic lesion induced by traditional Chinese drug is attended gradually. In order to control the severe consequence,the author analyzed the current situation and reasons of hepatic lesion induced by traditional Chinese drug,and suggested the prevention and drug risk management intervention for hepatic lesion induced by traditional Chinese drug.
Keywords:Traditional Chinese Medicine  hepatic lesion  drug risk management
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号